A selective endothelin ETA antagonist, BQ-123, inhibits125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells
- 1 April 1994
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 14 (2) , 105-118
- https://doi.org/10.1007/bf02090779
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- A novel subtype of endothelin B receptor mediating contraction in swine pulmonary veinLife Sciences, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Specific binding sites for 125I-endothelin-1 in the porcine and human spinal cordEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1Biochemical and Biophysical Research Communications, 1992
- A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptorsLife Sciences, 1992
- Functional endothelin-1 receptors in rat astrocytoma C6European Journal of Pharmacology: Molecular Pharmacology, 1991
- Specific receptors for endothelin‐3 in cultured bovine endothelial cells and its cellular mechanism of actionFEBS Letters, 1990
- Comparison of biological activities of endothelin-1, -2 and -3 in murine and human fibroblast cell linesBiochemical and Biophysical Research Communications, 1990
- Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cellsFEBS Letters, 1988
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985